fr
Article scientifique
Anglais

Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study

Publié dansThrombosis Research, vol. 162, p. 104-109
Date de publication2018
Résumé

The optimal duration of oral anticoagulant therapy after a first, unprovoked venous thromboembolism is controversial due to tightly balanced risks and benefits of indefinite anticoagulation. Risk stratification tools may assist in decision making.

Mots-clés
  • Anticoagulants/pharmacology/therapeutic use
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Pulmonary Embolism/etiology/pathology
  • Recurrence
  • Risk Factors
Citation (format ISO)
WAN, Tony et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. In: Thrombosis Research, 2018, vol. 162, p. 104–109. doi: 10.1016/j.thromres.2017.11.020
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal0049-3848
313vues
0téléchargements

Informations techniques

Création13/11/2018 12:03:00
Première validation13/11/2018 12:03:00
Heure de mise à jour15/03/2023 16:02:15
Changement de statut15/03/2023 16:02:14
Dernière indexation17/01/2024 05:10:38
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack